ULTRASE MT 18 (Ultrase MT 18 58,500 units amylase; 18,000 units lipase; 58,500 units protease)

Generic Name: pancrelipase

Pill with imprint ULTRASE MT 18 is Gray / White, Capsule-shape and has been identified as Ultrase MT 18 58,500 units amylase; 18,000 units lipase; 58,500 units protease. It is supplied by Axcan Scandipharm Inc..

Ultrase MT 18 is used in the treatment of chronic pancreatitis; pancreatic exocrine dysfunction; cystic fibrosis and belongs to the drug class digestive enzymes. Risk cannot be ruled out during pregnancy. Ultrase MT 18 58,500 units amylase; 18,000 units lipase; 58,500 units protease is not a controlled substance under the Controlled Substances Act (CSA).

Images for ULTRASE MT 18

Ultrase MT 18

Generic Name

pancrelipase

Imprint

ULTRASE MT 18

Strength

58,500 units amylase; 18,000 units lipase; 58,500 units protease

Color

Gray / White

Shape

Capsule-shape

Availability

Prescription only

Drug Class

Digestive enzymes

Pregnancy Category

C - Risk cannot be ruled out

CSA Schedule

Not a controlled drug

Labeler / Supplier

Axcan Scandipharm Inc.

National Drug Code (NDC)

58914-0018

More Info Imprint Search Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer